Ministry of Ayush sign MoU with Dept of Social Justice & Empowerment

IMT News Desk
IMT News Desk
· 3 min read

The MoU will help to enhance geriatric healthcare and combat substance abuse

The Ministry of Ayush and the Department of Social Justice and Empowerment (DoSJE) signed a Memorandum of Understanding (MoU) in New Delhi. The strategic partnership seeks to implement Ayush-based interventions to promote geriatric healthcare and combat substance abuse.

The MoU was signed by Prataprao Jadhav, Union Minister of State (Independent Charge), Ministry of Ayush, and BL Verma, Union Minister of State, Ministry of Social Justice and Empowerment. Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, Amit Yadav, Secretary and senior officials from both ministries were also present.

Jadhav, stated, “Geriatric healthcare and substance abuse are critical areas that require special focus, especially as we face an ageing population and growing concerns around addiction. This collaboration between the Ministry of Ayush and the Department of Social Justice and Empowerment represents a significant step towards addressing these challenges. By leveraging the holistic approach of Ayush systems alongside social welfare initiatives, we aim to empower our senior citizens and those affected by substance abuse.”

Verma, said, “The signing of the MoU with the Ministry of Ayush will benefit our senior citizens in a big way. The development of elderly-specific training modules, treatment protocols, yoga training programmes, sharing of preventive and curative practices, etc., under the MoU will go a long way in enabling our senior citizens to lead a healthy life. By joining hands with the Ministry of Ayush, I am sure that together we can provide comprehensive services to the community.”

Kotecha mentioned, “We have various programmes and initiatives to address the challenges being faced by the ageing population, such as the Geriatric Healthcare Camps under the National Ayush Mission. The Ministry of Ayush remains committed to enhancing the health and well-being of senior citizens, and this MoU will boost our efforts to provide quality health care to the senior citizens.”

Yadav said, “By signing of the MoU with Ayush, the Ministry will try to make this country a place free from any addiction to drugs with the help of Ayush by adopting their model of treatment and living a healthy life. And ensure that our senior citizens lead a healthy and dignified life by adopting a series of interventions devised through the Ministry of Ayush.

Key objectives of the MoU include:

  1. Cooperative efforts: Developing cooperation, convergence, and synergy between the Ministry of Ayush and DoSJE to foster innovative initiatives for promoting the health of senior citizens, reducing the demand for drugs, addressing substance abuse, and aiding mental rehabilitation. This will be achieved through awareness generation and capacity building of service providers using Ayush systems.
  2. Research Promotion: Encouraging research in the areas of geriatric health, substance abuse, and mental health, with a focus on exploring the therapeutic benefits of traditional healthcare practices.
  3. Health Promotion Activities: Supporting additional activities for health promotion tailored to both the geriatric population and individuals affected by substance abuse.

The MoU marks a significant milestone in India’s healthcare journey, combining the strengths of both Ayush systems and social justice initiatives to create a healthier and more inclusive society.

PIB

——-

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk